RAC-Alpha Serine/threonine-Protein Kinase (AKT1) Antibody

Este producto es parte de AKT1 - RAC-alpha serine/threonine-protein kinase 1
Product Graph
234€ (5 µg)

Por favor contáctenos para obtener información detallada sobre el precio y disponibilidad.

935106861
info@markelab.com
name
RAC-Alpha Serine/threonine-Protein Kinase (AKT1) Antibody
category
Primary Antibodies
provider
Abbexa
reference
abx137684

Description

RAC-Alpha Serine/threonine-Protein Kinase (AKT1) Antibody is a Mouse Monoclonal antibody against RAC-Alpha Serine/threonine-Protein Kinase (AKT1).

Documents del producto

Instrucciones
Data sheet
Descargar

Product specifications

Category
Primary Antibodies
Immunogen Target
RAC-Alpha Serine/threonine-Protein Kinase (AKT1)
Host
Mouse
Reactivity
Human
Clonality
Monoclonal
Size 1
5 µg
Size 2
20 µg
Size 3
100 µg
Availability
Shipped within 5-10 working days.
Dry Ice
No
Alias
AKT1,PKB,RAC,RAC-ALPHA
Background
Antibody anti-AKT1
Status
RUO

Descripción

The AKT (also known as Protein Kinase B) is a pivotal enzyme involved in regulating various cellular processes like metabolism, proliferation, survival, and growth. It acts downstream of phosphoinositide 3-kinase (PI3K) signaling pathway, which is activated by growth factors and cytokines. RAC-alpha serine/threonine-protein kinase is the full name of AKT. It belongs to the AGC (protein kinase A/protein kinase G/protein kinase C) family of kinases. AKT has three isoforms: AKT1, AKT2, and AKT3. Each isoform has slightly different tissue distributions and roles but shares the same basic structure and mechanism of action.Activation of AKT typically occurs through phosphorylation at two key residues: threonine 308 (Thr308) and serine 473 (Ser473). Once activated, AKT phosphorylates various downstream targets, including transcription factors, metabolic enzymes, and cell cycle regulators, ultimately leading to diverse cellular responses. Dysregulation of AKT signaling is implicated in various diseases, including cancer, diabetes, and cardiovascular diseases. Therefore, AKT has emerged as a significant target for therapeutic interventions in these conditions.

Related Products

EH0532

Human AKT1 (RAC-alpha serine/threonine-protein kinase) ELISA Kit

Ver Producto
EM1294

Mouse AKT1 (RAC-alpha serine/threonine-protein kinase) ELISA Kit

Ver Producto
ER1268

Rat AKT1 (RAC-alpha serine/threonine-protein kinase) ELISA Kit

Ver Producto